Clearside Biomedi (CLSD)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | CLSD | AMGN | VRTX | REGN | BMY |
| Company | Clearside Biomedi | Amgen Inc | Vertex Pharmaceutic | Regeneron Pharmaceuticals | Bristol-Myers Squibb Company |
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | NASDAQ | NYSE |
| Open | 1.3100 | 269.18 | 397.48 | 883.20 | 45.09 |
| High | 1.3500 | 276.36 | 399.31 | 897.78 | 45.38 |
| Low | 1.2800 | 268.99 | 394.35 | 883.20 | 44.53 |
| Last | 1.3000 | 275.79 | 395.24 | 892.07 | 44.61 |
| Change | -0.0400 | +5.81 | -2.24 | +8.87 | -0.24 |
| % Change | -2.99% | +2.15% | -0.56% | +1.00% | -0.54% |
| Volume | 60,941 | 1,394,303 | 370,812 | 228,640 | 10,847,140 |
| 20-Day Average Volume | 270,997 | 2,129,660 | 922,882 | 449,899 | 13,244,330 |
| Previous Close | 1.3400 | 269.98 | 397.48 | 883.20 | 44.85 |
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical |
| Has Options | Yes | Yes | Yes | Yes | Yes |
| Technicals | |||||
| 20-Day Moving Average | 1.3092 | 269.59 | 400.02 | 914.56 | 49.05 |
| 20-Day Raw Stochastic | 38.62% | 62.07% | 14.50% | 16.59% | 3.33% |
| 20-Day Relative Strength | 46.61% | 50.80% | 41.02% | 36.19% | 28.65% |
| Weighted Alpha | +13.52 | +13.27 | +12.10 | +14.69 | -35.36 |
| Today's Opinion | 8% Buy | 24% Sell | 8% Sell | 8% Buy | 88% Sell |
| Previous Opinion | 24% Buy | 72% Sell | 8% Buy | 8% Sell | 88% Sell |
| Last Month's Opinion | 88% Buy | 24% Buy | 56% Buy | 80% Buy | 24% Buy |
| Performance | |||||
| 5-Days | |||||
| %Chg | -7.50% since 04/22/24 | +1.17% since 04/22/24 | -1.15% since 04/22/24 | -1.17% since 04/22/24 | -9.16% since 04/22/24 |
| Low | 1.2600 on 04/25/24 | 265.72 on 04/26/24 | 393.00 on 04/25/24 | 875.22 on 04/26/24 | 44.34 on 04/26/24 |
| High | 1.4800 on 04/23/24 | 276.36 on 04/29/24 | 406.86 on 04/23/24 | 915.70 on 04/24/24 | 49.47 on 04/23/24 |
| 1-Month | |||||
| %Chg | -14.76% since 03/28/24 | -3.24% since 03/28/24 | -5.42% since 03/28/24 | -7.57% since 03/28/24 | -17.68% since 03/28/24 |
| Low | 1.1000 on 04/17/24 | 260.68 on 04/19/24 | 391.01 on 04/18/24 | 875.22 on 04/26/24 | 44.34 on 04/26/24 |
| High | 1.6288 on 04/02/24 | 283.91 on 04/02/24 | 421.45 on 04/01/24 | 970.20 on 04/01/24 | 54.23 on 04/01/24 |
| 3-Month | |||||
| %Chg | +0.32% since 01/29/24 | -12.23% since 01/29/24 | -9.29% since 01/29/24 | -6.92% since 01/29/24 | -10.49% since 01/29/24 |
| Low | 1.1000 on 04/17/24 | 260.68 on 04/19/24 | 391.01 on 04/18/24 | 875.22 on 04/26/24 | 44.34 on 04/26/24 |
| High | 2.1200 on 03/12/24 | 329.72 on 02/05/24 | 448.40 on 01/30/24 | 998.33 on 02/28/24 | 55.03 on 03/13/24 |
| 6-Month | |||||
| %Chg | +86.05% since 10/27/23 | +5.17% since 10/27/23 | +11.28% since 10/27/23 | +14.77% since 10/27/23 | -12.50% since 10/27/23 |
| Low | 0.6850 on 10/30/23 | 249.70 on 10/31/23 | 341.90 on 11/16/23 | 772.84 on 10/31/23 | 44.34 on 04/26/24 |
| High | 2.1200 on 03/12/24 | 329.72 on 02/05/24 | 448.40 on 01/30/24 | 998.33 on 02/28/24 | 55.03 on 03/13/24 |
| Key Statistics | |||||
| Market Capitalization, $K | 100,126 | 144,810,784 | 102,732,288 | 96,941,800 | 90,900,144 |
| Shares Outstanding, K | 74,721 | 536,376 | 258,459 | 109,762 | 2,026,759 |
| Annual Sales | 8,230,000 | 28,190,000,000 | 9,869,200,000 | 13,117,200,000 | 45,006,000,000 |
| Annual Net Income | -32,490,000 | 6,717,000,000 | 3,619,600,000 | 3,953,600,000 | 8,025,000,000 |
| Last Quarter Sales | 6,340,000 | 8,196,000,000 | 2,517,700,000 | 3,434,300,000 | 11,477,000,000 |
| Last Quarter Net Income | -4,830,000 | 767,000,000 | 968,800,000 | 1,159,600,000 | 1,762,000,000 |
| 60-Month Beta | 2.29 | 0.58 | 0.35 | 0.11 | 0.39 |
| Per-Share Information | |||||
| Most Recent Earnings | -0.08 on 03/12/24 | 4.71 on 02/06/24 | 4.20 on 02/05/24 | 11.86 on 02/02/24 | -4.40 on 04/25/24 |
| Latest Earnings Date | 05/09/24 | 05/02/24 | 05/06/24 | 05/02/24 | 04/25/24 |
| Most Recent Dividend | N/A | 2.250 on 02/15/24 | N/A | N/A | 0.600 on 04/04/24 |
| Next Ex-Dividends Date | N/A | 05/16/24 | N/A | N/A | 04/04/24 |
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 14.44 | 29.59 | 23.70 | 6.08 |